Data gathered: December 23
AI Stock Analysis - RxSight (RXST)
Analysis generated March 18, 2024. Powered by Chat GPT.
RxSight, a medical technology company, specializes in innovative solutions for vision correction. The company has been a pioneer in adjustable intraocular lens technology, which enables eye surgeons to refine patients' vision after cataract surgery. This technology distinguishes RxSight in the ophthalmology space, as it allows precise customization of the lens implant post-surgery. RxSight is dedicated to improving the quality of life for its patients by enhancing visual outcomes post-cataract surgery.
Stock Alerts - RxSight (RXST)
 |
RxSight | December 20 Price is down by -7.9% in the last 24h. |
|
RxSight | December 16 Price is up by 5% in the last 24h. |
|
RxSight | December 9 Price is down by -5.5% in the last 24h. |
|
RxSight | December 4 Insider Alert: Goldshleger Ilya is selling shares |
Alternative Data for RxSight
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 21 | Sign up | Sign up | Sign up |
| Sentiment | 93 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 24 | Sign up | Sign up | Sign up |
| Patents | 24 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 92 | Sign up | Sign up | Sign up |
| Facebook Followers | 598 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,863 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 294 | Sign up | Sign up | Sign up |
| Twitter Followers | 226 | Sign up | Sign up | Sign up |
| Twitter Mentions | 83 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 735 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 44 | Sign up | Sign up | Sign up |
| Linkedin Employees | 369 | Sign up | Sign up | Sign up |
About RxSight
RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
| Price | $33.66 |
| Target Price | Sign up |
| Volume | 2,220,000 |
| Market Cap | $1.36B |
| Year Range | $33.66 - $64.29 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical Devices |
In the news
 |
RxSight (NASDAQ:RXST) Lowered to Hold Rating by Stifel NicolausDecember 22 - ETF Daily News |
|
RxSight, Inc. (NASDAQ:RXST) Receives Consensus Recommendation of “Moderate Buy” from AnalystsDecember 22 - ETF Daily News |
|
State Street Corp Boosts Stock Holdings in RxSight, Inc. (NASDAQ:RXST)December 21 - ETF Daily News |
|
HighTower Advisors LLC Has $640,000 Position in RxSight, Inc. (NASDAQ:RXST)December 20 - ETF Daily News |
 |
Do You Believe in the Long-Term Growth Potential of RxSight (RXST)?December 19 - Yahoo |
 |
Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past yearDecember 19 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 35M | 36M | 25M | -6.3M | -9.2M | -0.160 |
| Q2 '24 | 35M | 35M | 24M | -6.1M | -7.5M | -0.160 |
| Q1 '24 | 30M | 32M | 21M | -9.1M | -7.9M | -0.250 |
| Q4 '23 | 29M | 32M | 18M | -9.2M | -9.8M | -0.260 |
| Q3 '23 | 21M | 28M | 14M | -12M | -13M | -0.310 |
Insider Transactions View All
| Goldshleger Ilya filed to sell 42,246 shares at $46.1. December 3 '24 |
| Goldshleger Ilya filed to sell 42,246 shares at $45.9. November 26 '24 |
| Maniar Shweta filed to sell 10,902 shares at $45.9. November 26 '24 |
| Goldshleger Ilya filed to sell 42,246 shares at $45.1. November 18 '24 |
| Goldshleger Ilya filed to sell 42,279 shares at $45. November 18 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$88.95 0% | 47 |
 |
Edwards LifesciencesEW |
$74.81 0% | 39 |
 |
Intuitive SurgicalISRG |
$524.43 0% | 74 |
 |
MedtronicMDT |
$81.03 0% | 54 |
 |
StrykerSYK |
$364.6 0% | 50 |
Read more about RxSight (RXST) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of RxSight?
The Market Cap of RxSight is $1.36B.
What is the current stock price of RxSight?
Currently, the price of one share of RxSight stock is $33.66.
How can I analyze the RXST stock price chart for investment decisions?
The RXST stock price chart above provides a comprehensive visual representation of RxSight's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling RxSight shares. Our platform offers an up-to-date RXST stock price chart, along with technical data analysis and alternative data insights.
Does RXST offer dividends to its shareholders?
As of our latest update, RxSight (RXST) does not offer dividends to its shareholders. Investors interested in RxSight should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of RxSight?
Some of the similar stocks of RxSight are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.